Clinical Trial Update: Safety and Efficacy of Conivaptan in Hyponatremic Patients With Symptomatic Acute Decompensated Heart Failure (ADHF) [Phase 3]

View source ↗

Summary

Phase 3 trial of conivaptan in hyponatremic patients with symptomatic acute decompensated heart failure was terminated; results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure
• Hyponatremia

Drugs mentioned

• Conivaptan (conivaptan)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Hyponatremia, Acute Decompensated Heart Failure | Phase 3 | Status: TERMINATED | Results posted: 2010-10-01